Back
Akero Therapeutics Stock Predictions

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
60
AKRO
Akero Therapeutics
Last Price:
$54.99
Seasonality Move:
30.3%
7 Day Trial
ALL ACCESS PASS
$
7

Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaAkero Therapeutics Stock Forecast
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 77.4% based on the past 5 years of stock performance.
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Akero Therapeutics Stock Undervalued?The current Akero Therapeutics [AKRO] share price is $54.90. The Score for AKRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Akero Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 77.4% based on the past 5 years of stock performance.
Akero Therapeutics Stock Rating
Buy
60
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics overpriced?
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Akero Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com
52-Week Data
52-Week High:
58.40
52-Week Low:
21.02
Prediction Charts
Market Cap:
4.4B
Price in USD:
54.90
Volume:
1.1M
Beta:
-0.03
Technical Analysis
SMA50:
44.82
SMA100:
45.58
SMA200:
37.22
52-Wk Change:
147.74%
Stock Predictions
-
Is Akero Therapeutics stock public?Yes, Akero Therapeutics is a publicly traded company.
-
What is the Akero Therapeutics stock quote today?The Akero Therapeutics stock price is 54.90 USD today.
-
How to buy Akero Therapeutics stock online?You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-30 | 47.55 | 49.65 | 51.66 | 47.17 |
Jun-2 | 49.75 | 50.73 | 51.32 | 48.65 |
Jun-3 | 51.23 | 51.61 | 51.85 | 50.70 |
Jun-4 | 51.55 | 52.99 | 53.48 | 51.38 |
Jun-5 | 52.81 | 53.94 | 54.21 | 52.15 |
Jun-6 | 54.24 | 54.28 | 55.87 | 54.13 |
Jun-9 | 55.49 | 54.71 | 57.07 | 52.28 |
Jun-10 | 54.00 | 54.52 | 54.82 | 53.04 |
Jun-11 | 54.80 | 52.96 | 55.46 | 52.29 |
Jun-12 | 52.51 | 53.56 | 54.36 | 51.42 |
Jun-13 | 52.19 | 55.62 | 55.83 | 52.19 |
Jun-16 | 55.65 | 55.75 | 55.80 | 53.14 |
Jun-17 | 55.40 | 55.40 | 56.49 | 54.43 |
Jun-18 | 54.84 | 54.90 | 55.33 | 53.61 |
Akero Therapeutics Earnings
Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Akero Therapeutics Forecast Revenue Growth
Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.